(Q33595360)

English

The chemokine receptor antagonist, TAK-779, decreased experimental autoimmune encephalomyelitis by reducing inflammatory cell migration into the central nervous system, without affecting T cell function

scientific article

Statements

The chemokine receptor antagonist, TAK-779, decreased experimental autoimmune encephalomyelitis by reducing inflammatory cell migration into the central nervous system, without affecting T cell function (English)
1 December 2009
2046-2056

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit